TCL Archive In Brief: Marks’ Appointment As President, Chief Executive Officer Of Memorial Sloan-Kettering, Official June 27, 1980
TCL Archive Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds January 29, 2010